By
As part of the deal, Rusnano and life sciences technologies investor Domain Associates are planning to co-invest in about 20 US-based healthcare technology companies.
Rusnano will invest up to $330 million while Domain's venture capital funds and other investors will invest a like amount, the companies said.
The remainder of the money will be used to establish a pharmaceutical and medical device manufacturing facility in Russia. At this facility, products will be manufactured that have been created by the companies the pair invest in.